AFM13 in patients with relapsed or refractory classical Hodgkin lymphoma: final results of an open-label, randomized, multicenter phase II trial

Sasse, S; Brockelmann, PJ; Momotow, J; Plutschow, A; Huttmann, A; Basara, N; Koenecke, C; Martin, S; Bentz, M; Grosse-Thie, C; Thorspecken, S; de Wit, M; Kobe, C; Dietlein, M; von Tresckow, B; Fuchs, M; Borchmann, P; Engert, A

Sasse, S (通讯作者)，Maria Hilf Hosp Moenchengladbach, Clin Hematol Oncol & Gastroenterol, Monchengladbach, Germany.

LEUKEMIA & LYMPHOMA, 2022; 63 (8): 1871

Abstract

In patients with relapse of classical Hodgkin lymphoma (cHL) after autologous stem cell transplant, brentuximab vedotin and anti-PD1 treatment, the ou......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索